ClinConnect ClinConnect Logo
Search / Trial NCT00152776

Treating Climacteric Symptoms With a Complex Homeopathic Remedy

Launched by HEIDELBERG UNIVERSITY · Sep 8, 2005

Trial Information

Current as of May 06, 2025

Completed

Keywords

Menopausal Symptoms Complementary Medicine

ClinConnect Summary

Complementary treatments for climacteric symptoms are used by many women although their efficacy and safety is mostly unproven.

The use of the complex homeopathic remedy Ovaria comp. for the relief of climacteric symptoms will be examined in this three-armed intervention trial and measured with the menopause rating scale II before and after each study phase of 12 weeks. Participants will receive the verum during two treatment phases of 12 weeks and the placebo during one treatment phase of 12 weeks in different sequences and are stratified for post- and perimenopausal status.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Climacteric symptoms\>=3 Points in Menopause Rating Scale (MRS) II
  • Communication possible
  • Exclusion Criteria:
  • Hormone replacement therapy within 2 weeks prior to study inclusion
  • Other complementary treatments 7 days before and during the study
  • Climacteric symptoms caused by operation, chemotherapy or hormonal therapy of cancer
  • Allergy to components of the remedy, especially bee poison

About Heidelberg University

Heidelberg University, a prestigious institution located in Germany, is renowned for its commitment to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university fosters a dynamic environment for conducting clinical trials that aim to enhance patient care and improve health outcomes. Leveraging cutting-edge technology and a robust network of healthcare professionals, Heidelberg University is dedicated to exploring novel therapeutic approaches and contributing to the global medical community through rigorous scientific inquiry and ethical research practices.

Locations

Heidelberg, Baden Württemberg, Germany

Patients applied

0 patients applied

Trial Officials

Cornelia U von Hagens, MD

Principal Investigator

Heidelberg University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials